FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)

View source ↗

Summary

FDA approves a supplemental application for LANOXIN (digoxin) filed by Covis Pharma US, Inc., resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Heart Failure

Drugs mentioned

• LANOXIN (Digoxin)

Snippet

SUPPL AP for LANOXIN (DIGOXIN)